Share This
Faculty and Staff Profiles

Cigdem Erkuran Yilmaz

Assistant Medical Professor

School/Division

Sophie Davis School of Biomedical Education

Department

Office

Harris Hall 309-B

p: 212-650-7101

f: 212-650-6812

e: cyilmaz@med.cuny.edu

  • Education

    M.D. - 1996, University of Ankara, Turkey

    Ph.D. - 2001, University of Ankara, Turkey
  • Research Interests

    Cardiovascular diseases are the major cause of mortality worldwide. Certain factors such as hypercholesterolemia, hypertension, nutrition and life style are associated with cardiovascular pathologies. Revealing the mechanisms by which these factors contribute to the cardiovascular disease pathogenesis is of prime importance in preventing and treating these diseases.

    Dr Erkuran Yilmaz's laboratory utilizes in vitro small vessel myography in combination with cell culture, molecular biology techniques and cardiovascular disease models such as hypertension, hypercholesterolemia and ischemic stroke.

    As a medical anatomist Dr Erkuran Yilmaz also conducts clinical human anatomy projects aiming documentation of anatomical variations for improved surgery and medical imaging techniques.





  • Publications

    Latest publications
    • Nagai M, Yilmaz CE, Kirchhofer D, Esmon CT, Mackman N, Granger DN. Role of Coagulation Factors in Cerebral Venous Sinus and Cerebral Microvascular Thrombosis. Neurosurgery. 2010 Mar; 66(3):560-566.

    • Nagai M, Terao S, Yilmaz G, Yilmaz CE, Esmon CT, Watanabe E, Granger DN. Roles of inflammation and the activated protein C pathway in the brain edema associated with cerebral venous sinus thrombosis. Stroke. 2010 Jan;41(1):147-52. Epub 2009 Nov 5.

    • Hideo Yoshida, Janice Russell, Karen Y. Stokes, Yilmaz CE, Charles T. Esmon, and D. Neil Granger. Role of the protein C pathway in the extra-intestinal thrombosis associated with murine colitis. Gastroenterology. 2008 Apr 22.

    • Carpenter A, Rassam A, Jennings MH, Robinson-Jackson S, Alexander JS, Erkuran-Yilmaz C. Effects of ammonium tetrathiomolybdate, an oncolytic/angiolytic drug on the viability and   proliferation of endothelial and tumor cells. Inflamm Res. 2007 Dec;56(12):515-9.

<< Back To Directory